BioNTech Investor Day Presentation Deck

A joint effort to build a mRNA manufacturing network The BioNTainer solution ensures: Partner contribution: Utilities BIONTAINER by BIONTECH M Indicative manufacturing network Potential partners for fill & finish BIONTAINER by BIONTECH M ---- H - M - H M - Acceleration of knowledge and technology transfer Rapid set-up of new mRNA manufacturing nodes for licensed mRNA vaccines Pandemic preparedness & other use cases Sustainability through maintenance and updating 4 = GMP BIONTECH 56 A Power supply, water connections, wastewater treatment, internet/network Access to talent Trainees, technicians, professionals Regulatory framework In collaboration with e.g. WHO, Africa CDC/AMA Operation permit Legal permission to run production Fill & finish capacity Local F&F for end-to-end manufacturing in Africa Logistics & supply Enabling manufacturing and dissemination

View entire presentation